| 0.99 -0.007 (-0.7%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.22 | 1-year : | 1.43 |
| Resists | First : | 1.04 | Second : | 1.22 |
| Pivot price | 0.92  |
|||
| Supports | First : | 0.89 | Second : | 0.8 |
| MAs | MA(5) : | 1 |
MA(20) : | 0.91 |
| MA(100) : | 1.05 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 76 |
D(3) : | 80.3 |
| RSI | RSI(14): 52.2 |
|||
| 52-week | High : | 3.44 | Low : | 0.47 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TRIB ] has closed below upper band by 34.0%. Bollinger Bands are 22% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.03 - 1.04 | 1.04 - 1.04 |
| Low: | 0.93 - 0.94 | 0.94 - 0.95 |
| Close: | 0.98 - 1 | 1 - 1.01 |
Tue, 18 Nov 2025
Trinity Biotech (Nasdaq: TRIB) Receives WHO Approval for Offshore Uni-Gold HIV Production - Stock Titan
Fri, 14 Nov 2025
Trinity Biotech (Nasdaq: TRIB) collaborates to advance EpiCapture analysis for prostate care - Stock Titan
Tue, 30 Sep 2025
Trinity Biotech Announces AGM Results and Board Changes - TipRanks
Tue, 02 Sep 2025
Trinity Biotech plc Regains Compliance with Nasdaq Minimum Bid Price and Market Value Requirements - Quiver Quantitative
Wed, 20 Aug 2025
TRIB’s Skyrocketing Shares: What’s Behind the Surge? - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 19 (M) |
| Shares Float | 325 (M) |
| Held by Insiders | 12 (%) |
| Held by Institutions | 72.7 (%) |
| Shares Short | 39 (K) |
| Shares Short P.Month | 108 (K) |
| EPS | -1.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.97 |
| Profit Margin | -51.7 % |
| Operating Margin | -42.8 % |
| Return on Assets (ttm) | -10.6 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 18.1 % |
| Gross Profit (p.s.) | 1.15 |
| Sales Per Share | 3.3 |
| EBITDA (p.s.) | -0.7 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.55 |
| PEG Ratio | 0 |
| Price to Book value | -0.5 |
| Price to Sales | 0.29 |
| Price to Cash Flow | -4.33 |
| Dividend | 1.1 |
| Forward Dividend | 0 |
| Dividend Yield | 112.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|